Alterity Therapeutics Ltd.ASX: ATH

Meeting with US FDA provides development path for ATH434

Jun 30, 2020 at 4:55 AM UTC · Issued by Alterity Therapeutics Ltd.

Alterity Therapeutics Ltd has released a press release.

View Attachment